Categoría

Europ. Associat. for the Study of the Liver

Home > Comunicaciones y Congresos > Europ. Associat. for the Study of the Liver (Page 2)

Prieto M, Lens S, Buti M, Pascasio JM, Fernández I, Mareque M, Torres C, Casado MA, Study Group on the Use of HBIg after liver transplantation in Spain

 

The use of prophylactic strategies using hepatitis B immunoglobulin for hepatitis B recurrence after liver transplantation in routine clinical practice in Spain
The International Liver Congress™ 2017. 52st Annual Meeting of the European Asocciation for the Study of the Liver (EASL). Amsterdam, Netherlands. 19-23 apr 2017

Buti M, Domínguez-Hernández R, Casado MA, Sabater E, Esteban R

 

 

Cost- effectiveness of screening for hepatitis C virus in population born between 1956 and 1970, in Spain
The International Liver Congress™ 2017. 52st Annual Meeting of the European Asocciation for the Study of the Liver (EASL). Amsterdam, Netherlands. 19-23 apr 2017

Buti M, Crespo J, Esteban R, Torres C, Oyagüez I, Casado MA

 

 

Cost-effectiveness analysis of hepatitis B virus screening to prevent hepatitis B virus reactivation in patients receiving rituximab based chemotherapy for hematologic malignancy
51st International Liver Congress. European Association for the Study of the liver (EASL). Barcelona, Spain. 13- 17 apr 2016

Buti M, Dominguez R, Oyagüez I, Rueda M, Casado MA

 

 

Early versus delayed use of Sofosbuvir plus Peginterferon/Ribavirin therapy in fibrosis patients with hepatitis C virus: A cost-effectiveness analysis
50th International Liver Congress (EASL). Vienna, Austria. 22- 26 apr 2015

Deniz B, Buti M, Brosa M, Casado MA, Rueda M, Everhard F, Esteban R

 

 

Cost-effectiveness simulation analysis of tenofovir disoproxil fumarate, lamivudine, adefovir dipivoxil and entecavir of HBeaAg negative patients with chronic hepatitis-B in Spain
43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milan, Italy. 23-27 apr 2008

Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R

 

 

The improved therapeutic effects of adefovir dipivoxil in patients with HBe-Ag-negative chronic hepatitis B offset against its increased cost compared to lamivudine
41st Annual Meeting of the European Association for the Study of the Liver (EASL). Vienna, Austria. 26-30 apr 2006

Wong JB, Buti M, Casado MA, Fosbrook L, Soriano V, Esteban R

 

 

Cost-effectiveness of peginterferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-HCV co-infected patients
40th Annual Meeting of the European Association for the Study of the Liver (EASL). Paris, France. 13-17 apr 2005

Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R

 

 

Cost-effectiveness of two oral antiviral therapies, lamivudine and adefovir dipivoxil of HBeAg-negative chronic hepatitis B
40th Annual Meeting of the European Association for the Study of the Liver (EASL). Paris, France. 13-17 apr 2005

Buti M, Wong J, Casado MA, Esteban R

 

 

 

Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients. Co-infected Patients
1st European Consensus Conference on the Treatment of Chronic Hepatitis B and C in HIV. Paris, France. 1-2 mar 2005